Filter Results :

Your search for Biosimilars returned 58 reports

Sort by


US Biosimilars Market Opportunity & Clinical Pipeline Analysis

02 Feb 2016  |  Published by:  KuicK Research
Pharmaceutical companies benefited from the revolution in biotechnology that hit US market in 1980s. Some of the blockbuster biologics have been introduced in market helping pharmaceutical companies to occupy major market shares. Their presence could be felt in every disease segment as they were im...

$ 2,400.00

Read More

Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020

04 Jan 2016  |  Published by:  MarketsandMarkets
The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin market in 2015. Market growth of human insulin products is being propelled by growing diabetes pa...

$ 4,650.00

Read More

Global Biologics and Biosimilars Industry Report 2015

19 Nov 2015  |  Published by:  QYResearch
The Global Biologics and Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the Biologics and Biosimilars industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Bi...

$ 2,800.00

Read More

Europe Biosimilars Market Opportunity Outlook 2020

01 Nov 2015  |  Published by:  KuicK Research
Burgeoning pressure on healthcare system has caused the regulators across the globe to look for suitable therapeutic options. Biologic drugs are commonly used for treatment of various diseases but they are costly and their alternative options are difficult to find. Biosimilars have come forth as new...

$ 2,400.00

Read More

Global Oncology Biosimilars Industry 2015 Market Research Report

19 Aug 2015  |  Published by:  QYResearch
The Global Oncology Biosimilars Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Oncology Biosimilars industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.T...

$ 2,800.00

Read More

The 2016-2021 Outlook for Biosimilars in India

01 Aug 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the latent demand outlook for biosimilars across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 5,100 cities in India. For each city in question, the...

$ 595.00

Read More

The 2016-2021 Outlook for Biosimilars in Japan

01 Aug 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the latent demand outlook for biosimilars across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. This statistical approach can prove very use...

$ 595.00

Read More

The 2016-2021 Outlook for Biosimilars in the United States

01 Aug 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the latent demand outlook for biosimilars across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,700 cities in the United States. For each city in questio...

$ 595.00

Read More

The 2016-2021 Outlook for Biosimilars in Greater China

01 Aug 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the latent demand outlook for biosimilars across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (H...

$ 595.00

Read More

Global Biosimilars Industry Report 2015

21 Jul 2015  |  Published by:  QYResearch
The Global Biosimilars Industry Report 2015 is a professional and in-depth study on the current state of the Biosimilars industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars market analysis is...

$ 2,800.00

Read More

Global Biosimilars Industry 2015 Market Research Report

17 Jul 2015  |  Published by:  9Dimen Research
2015 Global Biosimilars Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilars industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).The repor...

$ 2,850.00

Read More

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

16 Jul 2015  |  Published by:  MarketsandMarkets
Report Description Various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. Some of these factors include the rising pressure to reduce healthcare expenditure, growing demand for cost-effective alternatives, growing burden of c...

$ 4,650.00

Read More

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 - a G-CSF & GM-CSF Competitor Analysis

13 Jul 2015  |  Published by:  La Merie Business Intelligence
The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 a G-CSF & GM-CSF Competitor Analysis describes product portfolios and R&D pipelines of granulocyte colony stimulating factor (G-CSF) and GM-CSF products and product candidates in regulate...

$ 447.16

Read More

Global Cancer Biosimilars Market Opportunity Outlook

23 Jun 2015  |  Published by:  KuicK Research
Cancer incidences are escalating tremendously across the globe due to which burgeoning pressure has been created on pharmaceutical companies to come forth with viable products. Moreover, presently available drugs for cancer treatment are known for their superior ph...

$ 1,800.00

Read More

Biosimilars - Regulatory Framework and Pipeline Analysis

01 Jun 2015  |  Published by:  GBI Research
SummaryBiosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price will ...

$ 2,995.00

Read More
Total 58 records.